2024-02-21


Huanghai Pharmaceutical, a subsidiary of Baheal Pharmaceutical, was awarded the title of "Top 100 Enterprises with Economic Contributions in Baoshan District, Shanghai in 2023"

 

At the 2024 Baoshan District Optimizing Business Environment and Investment Promotion Conference held recently, Shanghai Baheal Pharmaceutical Co., Ltd. (referred to as "Baheal Pharma"), a wholly-owned subsidiary of Shanghai Huanghai Pharmaceutical Co., Ltd. (hereinafter referred to as "Huanghai Pharmaceutical"), was awarded the title of "Top 100 Economic Contributing Enterprises of Baoshan District in 2023" for its contributions to the economic and social development of the entire region.

 

As a registered and operating enterprise in Baoshan District, Huanghai Pharmaceutical has been committed to drug research and development, production, and sales for many years, providing high-quality drugs and services to patients. With excellent product quality and good market reputation, Huanghai Pharmaceutical has won the honors of Shanghai High tech Enterprise, Shanghai Quality Benchmark Enterprise, Shanghai Speciality, Specialty and New Enterprise, 2022 Top 100 traditional Chinese patent medicines and simple preparations Enterprises, etc. The main products of the company, Fuzheng Huayu, have been included in the National Medical Insurance Drug Catalog and the National Essential Drug Catalog.

 

In the past year, Huanghai Pharmaceutical has maintained a strong development momentum. The company has increased investment in research and development, improved its ability to develop innovative products, actively expanded sales channels, deepened cooperation with partners, continuously improved its competitiveness and innovation, and reached a new level of development. At the same time, Huanghai Pharmaceutical actively fulfills its social responsibility, pays attention to social public welfare undertakings, focuses on cultivating medical talents, and assists in rural revitalization. The company also actively promotes energy conservation and emission reduction, completes the certification of environmental management system, occupational health and safety management system, and energy management system, and has been awarded the title of "Green Factory" in Shanghai. With practical actions, it has won widespread praise and established a good reputation.

 

Being awarded the title of "Top 100 Enterprises with Economic Contributions in 2023" is both an honor and a responsibility for Huanghai Pharmaceutical. In the future, Huanghai Pharmaceutical will continue to adhere to the development concept of innovation driven and quality oriented, continuously improve product quality and service level, provide better drugs and services for patients, and contribute more to the economic development and social progress of Baoshan District.

Previous:

Next: